121 related articles for article (PubMed ID: 8397587)
1. Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site.
Nichols AC; Yielding KL
Mol Chem Neuropathol; 1993 Aug; 19(3):269-82. PubMed ID: 8397587
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant activity of 4-urea-5,7-dichlorokynurenic acid derivatives that are antagonists at the NMDA-associated glycine binding site.
Nichols AC; Yielding KL
Mol Chem Neuropathol; 1998; 35(1-3):1-12. PubMed ID: 10343967
[TBL] [Abstract][Full Text] [Related]
3. Glycine derivatives of imidazolones as potential ligands of glycine binding site of NMDA receptors. Part 1.
Kieć-Kononowicz K; Karolak-Wojciechowska J; Handzlik J
Acta Pol Pharm; 1998; 55(5):381-8. PubMed ID: 9921116
[TBL] [Abstract][Full Text] [Related]
4. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
Tricklebank MD; Bristow LJ; Hutson PH; Leeson PD; Rowley M; Saywell K; Singh L; Tattersall FD; Thorn L; Williams BJ
Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
Wlaź P; Poleszak E
Pharmacol Rep; 2011; 63(5):1231-4. PubMed ID: 22180366
[TBL] [Abstract][Full Text] [Related]
6. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs.
Kamiński R; Przywara B; Gasior M; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(2-3):133-46. PubMed ID: 9660092
[TBL] [Abstract][Full Text] [Related]
8. Anticonvulsant activity of novel derivatives of 2- and 3-piperidinecarboxylic acid in mice and rats.
Hinko CN; Crider AM; Kliem MA; Steinmiller CL; Seo TH; Ho B; Venkatarangan P; el-Assadi AA; Chang H; Burns CM; Tietz EI; Andersen PH; Klitgaard H
Neuropharmacology; 1996; 35(12):1721-35. PubMed ID: 9076751
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant effects of eliprodil alone or combined with the glycineB receptor antagonist L-701,324 or the competitive NMDA antagonist CGP 40116 in the amygdala kindling model in rats.
Wlaź P; Ebert U; Löscher W
Neuropharmacology; 1999 Feb; 38(2):243-51. PubMed ID: 10218865
[TBL] [Abstract][Full Text] [Related]
11. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
Parsons CG; Danysz W; Quack G; Hartmann S; Lorenz B; Wollenburg C; Baran L; Przegalinski E; Kostowski W; Krzascik P; Chizh B; Headley PM
J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist.
Baron BM; Harrison BL; Kehne JH; Schmidt CJ; van Giersbergen PL; White HS; Siegel BW; Senyah Y; McCloskey TC; Fadayel GM; Taylor VL; Murawsky MK; Nyce P; Salituro FG
Eur J Pharmacol; 1997 Apr; 323(2-3):181-92. PubMed ID: 9128837
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of alkyl- and alkoxy-substituted 1,4-dihydroquinoxaline-2,3-diones: potent and systemically active antagonists for the glycine site of the NMDA receptor.
Cai SX; Kher SM; Zhou ZL; Ilyin V; Espitia SA; Tran M; Hawkinson JE; Woodward RM; Weber E; Keana JF
J Med Chem; 1997 Feb; 40(5):730-8. PubMed ID: 9057859
[TBL] [Abstract][Full Text] [Related]
14. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
15. Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice.
Wlaź P; Baran H; Löscher W
Eur J Pharmacol; 1994 May; 257(3):217-25. PubMed ID: 8088343
[TBL] [Abstract][Full Text] [Related]
16. Blockade of the NMDA receptor-associated glycine site and the protective activity of antiepileptic drugs in electroshock-induced seizures in mice.
Kamiński R; Przywara B; Gasior M; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 1997; 49(1):70-1. PubMed ID: 9431559
[No Abstract] [Full Text] [Related]
17. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.
Peterson SL
Eur J Pharmacol; 1991 Jul; 199(3):341-8. PubMed ID: 1655484
[TBL] [Abstract][Full Text] [Related]
18. 7-Chlorokynurenic acid antagonizes the anticonvulsant activity of D-cycloserine in maximal electroshock seizures.
Peterson SL
Epilepsy Res; 1992 Oct; 13(1):73-81. PubMed ID: 1478199
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
[TBL] [Abstract][Full Text] [Related]
20. Potent indole- and quinoline-containing N-methyl-D-aspartate antagonists acting at the strychnine-insensitive glycine binding site.
Baron BM; Harrison BL; McDonald IA; Meldrum BS; Palfreyman MG; Salituro FG; Siegel BW; Slone AL; Turner JP; White HS
J Pharmacol Exp Ther; 1992 Sep; 262(3):947-56. PubMed ID: 1388205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
